Buy Curos Caps Today

This official Summary of Peer-Reviewed Studies compiles data from multiple medical centers showing infection rate declines (e.g., from 1.36 to 0.47 per 1,000 catheter days) and high staff preference (100% in some audits) for caps over manual scrubbing. Benefits Highlighted in Literature

analyzed over 200,000 hospitalizations during the COVID-19 pandemic. It found a in patients using Curos caps compared to standard "scrub the hub" protocols. buy curos caps

A 2024 meta-analysis in Infection Control and Hospital Epidemiology confirmed that antiseptic barrier caps significantly reduce infection rates, particularly in ICUs, and found them highly cost-effective with median savings of $21,890 per CLABSI prevented. This official Summary of Peer-Reviewed Studies compiles data

, several high-quality research papers and clinical summaries highlight their effectiveness in reducing hospital-acquired infections and saving costs. Key Research & Clinical Papers A 2024 meta-analysis in Infection Control and Hospital

A study published in ClinicoEconomics and Outcomes Research

If you are looking for evidence to support buying or implementing 3M Curos Disinfecting Caps Go to product viewer dialog for this item.

Research in the American Journal of Infection Control showed that implementation of Curos caps